Brief: Kimia Biosciences Gets Nod To Manufacture New API
29/04/2020 06:39
April 29 (Reuters) - Kimia Biosciences Ltd KIMI.BO :
* GRANTED PERMISSION TO MANUFACTURING AND MARKETING OF NEW
ACTIVE
PHARMACEUTICAL INGREDIENT AZELNIDIPINE DRUG
* PERMISSION BY INDIA'S CENTRAL DRUGS STANDARD CONTROL
ORGANIZATION
Source text for Eikon: ID:nBSEb4558m
Further company coverage: KIMI.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kimia Biosciences
See all newsBrief: Kimia Biosciences Ltd Says Naveen Sharma Resigns As CFO
Brief: Kimia Biosciences Appoints Naveen Sharma As CFO
Brief: Kimia Biosciences Pradip Kumar Sharma Resigns as Chief Financial Officer
Brief: Kimia Biosciences Says Rakesh Chetani Resigns As CFO
Brief: Kimia Biosciences Gets Order Worth $200,000